Ribomic Inc
TSE:4591

Watchlist Manager
Ribomic Inc Logo
Ribomic Inc
TSE:4591
Watchlist
Price: 80 JPY -1.23% Market Closed
Market Cap: 3.3B JPY
Have any thoughts about
Ribomic Inc?
Write Note

Ribomic Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ribomic Inc
Operating Income Peer Comparison

Comparables:
2160
4587
4974
2929
C
4894

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Ribomic Inc
TSE:4591
Operating Income
-ÂĄ1.1B
CAGR 3-Years
6%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Operating Income
ÂĄ9.4B
CAGR 3-Years
56%
CAGR 5-Years
56%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Operating Income
ÂĄ32.4B
CAGR 3-Years
83%
CAGR 5-Years
55%
CAGR 10-Years
66%
Takara Bio Inc
TSE:4974
Operating Income
ÂĄ739m
CAGR 3-Years
-68%
CAGR 5-Years
-33%
CAGR 10-Years
-11%
Pharma Foods International Co Ltd
TSE:2929
Operating Income
ÂĄ5.1B
CAGR 3-Years
-3%
CAGR 5-Years
55%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Operating Income
-ÂĄ588.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ribomic Inc's Operating Income?
Operating Income
-1.1B JPY

Based on the financial report for Jun 30, 2024, Ribomic Inc's Operating Income amounts to -1.1B JPY.

What is Ribomic Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-4%

Over the last year, the Operating Income growth was 28%. The average annual Operating Income growth rates for Ribomic Inc have been 6% over the past three years , -4% over the past five years .

Back to Top